Growth Metrics

SOPHiA GENETICS (SOPH) EPS (Weighted Average and Diluted) (2022 - 2025)

SOPHiA GENETICS recorded quarterly EPS (Weighted Average and Diluted) of -$35406.8 in Q2 2025, down 4.76% quarter-over-quarter from -$33797.7 in Q2 2024, and down 4.76% year-over-year from -$37176.7 in Q2 2024.

SOPHiA GENETICS's EPS (Weighted Average and Diluted) history runs 4 years deep, the most recent figure standing at -$35406.8 for Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn 1.48
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 0.67
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 0.82
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 0.41
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 0.10
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 0.22
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn -0.10
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn 0.02
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 0.25
10 SOPHiA GENETICS 24.12 Mn -46.17 Mn 14.69 Mn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 -35,406.78
Jun 30, 2024 -33,797.73
Jun 30, 2023 -33,203.13
Mar 31, 2023 -487,150.00
Jun 30, 2022 -31,657.69
Mar 31, 2022 -417,016.67